DK1049468T3 - Anvendelse af hydroxypyridonholdige pudderpræparater til behandling af skinnebens- og tryksår - Google Patents

Anvendelse af hydroxypyridonholdige pudderpræparater til behandling af skinnebens- og tryksår

Info

Publication number
DK1049468T3
DK1049468T3 DK99902528T DK99902528T DK1049468T3 DK 1049468 T3 DK1049468 T3 DK 1049468T3 DK 99902528 T DK99902528 T DK 99902528T DK 99902528 T DK99902528 T DK 99902528T DK 1049468 T3 DK1049468 T3 DK 1049468T3
Authority
DK
Denmark
Prior art keywords
hydroxypyridone
tibia
treatment
containing powder
pressure ulcers
Prior art date
Application number
DK99902528T
Other languages
English (en)
Inventor
Manfred Bohn
Karl Theodor Kraemer
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Application granted granted Critical
Publication of DK1049468T3 publication Critical patent/DK1049468T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
DK99902528T 1998-01-24 1999-01-11 Anvendelse af hydroxypyridonholdige pudderpræparater til behandling af skinnebens- og tryksår DK1049468T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19802708A DE19802708A1 (de) 1998-01-24 1998-01-24 Verwendung von hydroxypyridon-haltigen Puderzubereitungen zur Behandlung von Unterschenkel- und Druckgeschwüren
PCT/EP1999/000105 WO1999037300A1 (de) 1998-01-24 1999-01-11 Verwendung von hydroxypyridon-haltigen puderzubereitungen zur behandlung von unterschenkel- und druckgeschwüren

Publications (1)

Publication Number Publication Date
DK1049468T3 true DK1049468T3 (da) 2007-07-30

Family

ID=7855595

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99902528T DK1049468T3 (da) 1998-01-24 1999-01-11 Anvendelse af hydroxypyridonholdige pudderpræparater til behandling af skinnebens- og tryksår

Country Status (27)

Country Link
US (1) US6534528B1 (da)
EP (1) EP1049468B1 (da)
JP (1) JP5127091B2 (da)
KR (1) KR100597332B1 (da)
CN (1) CN1128619C (da)
AR (1) AR016445A1 (da)
AT (1) ATE360418T1 (da)
AU (1) AU752406B2 (da)
BR (1) BR9907734A (da)
CA (1) CA2319359C (da)
CY (1) CY1106684T1 (da)
DE (2) DE19802708A1 (da)
DK (1) DK1049468T3 (da)
ES (1) ES2285829T3 (da)
HR (1) HRP20000496A2 (da)
HU (1) HU228824B1 (da)
IL (1) IL137453A (da)
ME (1) ME00390B (da)
NZ (1) NZ505898A (da)
PL (1) PL192550B1 (da)
PT (1) PT1049468E (da)
RS (1) RS50903B (da)
RU (1) RU2212239C2 (da)
SI (1) SI1049468T1 (da)
SK (1) SK285350B6 (da)
TR (1) TR200002118T2 (da)
WO (1) WO1999037300A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001122804A (ja) * 1999-10-28 2001-05-08 Sato Pharmaceutical Co Ltd リン酸コーンスターチ配合外用医薬組成物
EP1354586A1 (en) * 2002-04-20 2003-10-22 Aventis Pharma Deutschland GmbH The use of hydroxpyridone-derivatives in wound healing
US20060257439A1 (en) * 2005-03-29 2006-11-16 Sabnis Ram W Cleansing compositions with color changing indicator
RU2326665C1 (ru) * 2007-04-03 2008-06-20 Марвел ЛайфСайнсез Лимитед, Великобритания Средство, обладающее противогипоксическим, противоинсультным, улучшающим память действием
BR112013001953A2 (pt) * 2010-07-27 2018-05-15 Clariant Finance Bvi Ltd uso de hidroxipiridonas ou sais dos mesmos para a estabilização de peróxido de hidrogênio ou substâncias doadoras de peróxido de hidrogênio
MX2013001095A (es) * 2010-07-27 2013-03-12 Clariant Finance Bvi Ltd Composiciones que comprenden peroxido de hidrogeno o sustancias donadoras de peroxido de hidrogeno.
WO2016164308A1 (en) 2015-04-06 2016-10-13 Subdomain, Llc De novo binding domain containing polypeptides and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2540218A (en) 1947-08-25 1951-02-06 Squibb & Sons Inc 2-hydroxy-pyridine-n-oxide and process for preparing same
DE3779352D1 (de) 1986-04-18 1992-07-02 Hoechst Ag 1-hydroxy-2-pyridone, verfahren zu ihrer herstellung und arzneimittel, die sie enthalten, sowie bei der herstellung der 1-hydroxy-2-pyridone gebildete zwischenprodukte.
JPS63264504A (ja) * 1987-04-17 1988-11-01 Shinto Paint Co Ltd 工業用防カビ組成物
US4956184A (en) * 1988-05-06 1990-09-11 Alcide Corporation Topical treatment of genital herpes lesions
CA2046801C (en) * 1990-08-07 2002-02-26 Peter D. Davis Substituted pyrroles
DE4333893A1 (de) * 1993-10-05 1995-04-06 Hoechst Ag Kosmetische Zubereitungen
ATE217524T1 (de) * 1995-12-04 2002-06-15 Aventis Pharma Gmbh Verwendung von 1-hydroxy-2-pyridonen zur behandlung von schwer therapierbaren schleimhauterkrankungen

Also Published As

Publication number Publication date
US6534528B1 (en) 2003-03-18
SK285350B6 (sk) 2006-11-03
EP1049468A1 (de) 2000-11-08
TR200002118T2 (tr) 2000-12-21
JP2002501020A (ja) 2002-01-15
IL137453A (en) 2005-11-20
PL342055A1 (en) 2001-05-21
CA2319359C (en) 2008-03-18
MEP55908A (en) 2011-05-10
PL192550B1 (pl) 2006-11-30
SK10892000A3 (sk) 2000-12-11
BR9907734A (pt) 2000-10-17
HRP20000496A2 (en) 2000-12-31
ATE360418T1 (de) 2007-05-15
YU43700A (sh) 2003-08-29
AR016445A1 (es) 2001-07-04
RU2212239C2 (ru) 2003-09-20
SI1049468T1 (sl) 2007-08-31
NZ505898A (en) 2002-06-28
DE59914312D1 (de) 2007-06-06
HU228824B1 (en) 2013-05-28
IL137453A0 (en) 2001-07-24
CA2319359A1 (en) 1999-07-29
DE19802708A1 (de) 1999-07-29
EP1049468B1 (de) 2007-04-25
CN1288380A (zh) 2001-03-21
HK1034447A1 (en) 2001-10-26
CY1106684T1 (el) 2012-05-23
AU752406B2 (en) 2002-09-19
RS50903B (sr) 2010-08-31
HUP0200851A3 (en) 2003-05-28
KR20010034325A (ko) 2001-04-25
KR100597332B1 (ko) 2006-07-10
AU2278799A (en) 1999-08-09
JP5127091B2 (ja) 2013-01-23
ES2285829T3 (es) 2007-11-16
ME00390B (me) 2011-05-10
WO1999037300A1 (de) 1999-07-29
PT1049468E (pt) 2007-05-31
HUP0200851A1 (hu) 2002-07-29
CN1128619C (zh) 2003-11-26

Similar Documents

Publication Publication Date Title
DK0956858T3 (da) Farmaceutiske præparater indeholdende lactobacilli til behandling af vaginale infektioner
EP1283702A4 (en) MEDICAL ASSOCIATION ARRANGEMENT AND METHOD OF THE APPLICATION
NO994613D0 (no) Fremgangsmaate og preparat til behandling av sövn-apne
PL332934A1 (en) The use of nano-dispersion for final cosmetic preparations
DK0941103T3 (da) Farmaceutisk præparat til behandling af diabetes
IT1296619B1 (it) Procedimento per il trattamento di protesi a struttura aperturata e relativi dispositivi.
ID16493A (id) Perlakuan bahan yang mengandung padatan yang diambil dari efluen
FI971969A0 (fi) Peräpukamien hoitoon tarkoitettuja koostumuksia ja käyttömenetelmä
DE69830728D1 (de) Arzneimittel zur behandlung von häufigem wasserlassen und harninkontinenz
PL332935A1 (en) The use of nano-dispersion for final cosmetic preparations
NO20015516D0 (no) Preparater og anvendelser av ET743 for behandling av kreft
DK1032408T3 (da) Galenisk præparat til forebyggelse og behandling af leverkarcinom
NO20024775D0 (no) Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
NO20015542D0 (no) Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner
DK199800837A (da) Anlæg til behandling af emner
FI965204A0 (fi) Bromelaiinin lääkekäyttö
NO991459L (no) Anvendelse av 1-hydroksy-2-pyridoner til behandling av hudinfeksjoner
DK1041985T3 (da) Kombination af benzocycloheptapyridinforbindelser og antineoplastiske lægemidler til behandling af profilerative sygdomme
NO20024776D0 (no) Hydroksyfenyl-piperazinyl-metyl-benzamidderivater til behandling av smerte
ATE298576T1 (de) Arzneizubereitungen
NO20024777D0 (no) Kinolinyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
NO995838D0 (no) Nye heteroetynylenforbindelser og farmasöytiske og kosmetiske preparater inneholdende de samme
NO20004920D0 (no) Anvendelse av proteaseinhibitorer for behandling av hudskader
DE59914312D1 (de) Verwendung von hydroxypyridon-haltigen puderzubereitungen zur behandlung von unterschenkel- und druckgeschwüren
EE200300057A (et) Koostis vähi profülaktikaks ja raviks